Barclays
OTIC

Barclays’s Otonomy, Inc. OTIC Stock Holding History

Barclays’s Portfolio OTIC Stock Details OTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-64,400
Closed -$209K – 7199
2017
Q3 		$209K Buy
+64,400
New +$868K ﹤0.01% 4390
2016
Q4 		– Sell
-50,000
Closed -$910K – 6914
2016
Q3 		$910K Buy
+50,000
New +$817K ﹤0.01% 2716

Other funds holding OTIC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Barclays's OTIC Position: Q2 2022 in Review

Barclays sold out of Otonomy, Inc. (OTIC) in Q2 2022, closing a stake of 777 shares — an estimated $2K sold.

Barclays first reported a position in OTIC in Q4 2014 and held it in 29 quarters. The position peaked at $809K in Q4 2017. 50 funds tracked by Wall St. Rank hold OTIC as of Q2 2022.

  • Barclays reported no remaining Otonomy, Inc. position as of Q2 2022 after selling out during the quarter.
  • Barclays sold 777 Otonomy, Inc. shares in Q2 2022, an estimated $2K.
  • Barclays first reported a position in Otonomy, Inc. in Q4 2014 and held it in 29 quarters.
  • Barclays's Otonomy, Inc. position peaked at $809K in Q4 2017.
  • 50 funds tracked by Wall St. Rank held Otonomy, Inc. as of Q2 2022.

Based on Barclays's 13F filing for Q2 2022, filed 12 Aug 2022.